Monday, 7 July 2014
Thursday's active movers include Amgen, Nokia, Vonage
NEW YORK (CNNMoney.com) -- The following are some of Thursday's most actively traded stocks:
Amgen (up $2.97 to $62.98, Charts, Fortune 500) said its anemia drug Aranesp showed no increased risk of death compared to a placebo in a study of small-cell lung cancer patients undergoing chemotherapy.
Briggs & Stratton (down $3.06 to $28.74, Charts) reported earnings that fell sharply in the wake of a mild U.S. hurricane season, and the company cut its profit forecast for the year.
Continental Airlines (down $1.36 to $42.38, Charts, Fortune 500) posted a higher-than-expected first quarter profit helped by fuller planes, higher fares and a slight decline in fuel prices.
Harley-Davidson (up $2.44 to $63.70, Charts, Fortune 500) reported better-than-expected results despite a strike at a key plant.
Southwest Airlines Co. (down $0.01 to $15.65, Charts, Fortune 500) posted higher first-quarter earnings despite higher jet fuel costs.
Marriott (down $3.68 to $48.19, Charts, Fortune 500) reported a quarterly profit that nearly tripled, helped by higher room rates, but the company lowered its outlook for full-year room revenue.
Altria Group (down $0.71 to $69.37, Charts, Fortune 500) posted quarterly earnings below analysts' forecasts due to weakness at its Phillip Morris USA tobacco business.
Nokia Corp. (up $0.84 to $24.71, Charts) reported a robust profit margin for the first quarter helped by buoyant emerging market demand, pushing its shares to a 12-month high.
New York Times Company (down $0.52 to $24.04, Charts) said its first-quarter profit fell 26 percent, hurt by weakness in print advertising and various charges.
Playtex Products (up $1.53 to $15.06, Charts) said Thursday it has acquired the owner of the Hawaiian Tropic sun care line, Tiki Hut Holding, expanding its sun care lineup ahead of the summer season.
Schering-Plough Corporation (up $2.49 to $31.04, Charts, Fortune 500) posted a 55 percent rise in first-quarter earnings, beating analysts' expectations on higher sales of its prescription drugs, including two cholesterol fighters sold in partnership with Merck & Co.
Unitedhealth Group (down $2.08 to $52.13, Charts, Fortune 500) said its first-quarter profit rose 4 percent, but the results were hampered by payments related to its stock options problems.
Vonage (down $0.09 to $3.02, Charts) disclosed in an SEC filing that its litigation with Verizon could force it into bankruptcy.
Wyeth (Charts, Fortune 500) said earnings rose a better-than-expected 12 percent on strong sales of its vaccine against childhood infections, and it reported positive trial results for its experimental drug Pristiq.
To see the original post along with any additional graphics or video, navigate to the link previously mentioned